Skip to main navigation Skip to search Skip to main content

Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disability

  • Jon Allard
  • , William Henley
  • , Adrian Sellers
  • , Emma O'Shaughnessy
  • , Oliver Thomson
  • , Brendan McLean
  • , Mary Parrett
  • , Sanjeev Rajakulendran
  • , Lance Watkins
  • , Melissa Maguire
  • , Shan Ellawela
  • , Phil Tittensor
  • , Arjune Sen
  • , Rajiv Mohanraj
  • , Manny Bagary
  • , Sunil Ram
  • , Allan Brown
  • , Rohit Shankar*
  • *Corresponding author for this work
  • Cornwall Partnership NHS Foundation Trust
  • University of Exeter
  • Royal Cornwall Hospitals NHS Trust
  • University College London
  • Swansea Bay University Health Board
  • Leeds Teaching Hospitals NHS Trust
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Royal Wolverhampton Hospitals NHS Trust
  • Oxford University Hospitals NHS Foundation Trust
  • Northern Care Alliance NHS Group
  • Birmingham and Solihull Mental Health NHS Foundation Trust
  • Somerset NHS Foundation Trust
  • Lancashire Teaching Hospitals NHS Foundation Trust

Research output: Contribution to journalArticlepeer-review

28 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Efficacy and tolerability of Brivaracetam in people with intellectual disability compared to those without intellectual disability'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Psychology